Brief: Cancer Genetics And Stemonix Announce Joint Proof-Of-Concept Program
03/09/2020 13:41
Sept 3 (Reuters) - Cancer Genetics Inc CGIX.O :
* CANCER GENETICS AND STEMONIX ANNOUNCE JOINT
PROOF-OF-CONCEPT
PROGRAM
Source text for Eikon: ID:nGNXPjfnt
Further company coverage: CGIX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vyant Bio
See all newsBrief: Vyant Bio Provides Update On Winddown Activities
Brief: Vyant Bio Announces Stockholder Approval Of Plan Of Dissolution
Brief: Vyant Bio Files Form 15 For Voluntary Nasdaq Delisting And SEC Deregistration
Brief: Vyant Bio Announces Filing Of Form 25 For Voluntary Nasdaq Delisting And SEC Deregistration
Brief: Vyant Bio Announces Voluntary Nasdaq Delisting, SEC Deregistration